SCHEMBL31723124

SCHEMBL31723124

O=C(O)c1c(-c2cccc(F)c2)oc2ccc(Cl)cc2c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
MAPT P10636 2/20 0.57
HTT P42858 2/20 0.57
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPC1 O15118 1/20 0.57
HPGD P15428 1/20 0.57
RAB9A P51151 1/20 0.57
ADORA3 P0DMS8 2/20 0.55
GABRP O00591 4/20 0.55
GABRD O14764 4/20 0.55
GABRA1 P14867 4/20 0.55
GABRB1 P18505 4/20 0.55
GABRG2 P18507 4/20 0.55
GABRB3 P28472 4/20 0.55
GABRA5 P31644 4/20 0.55
GABRA3 P34903 4/20 0.55
GABRA2 P47869 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20918175 1.00 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL22284777 0.92 TTR (0.49) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL31723151 0.92 TTR (0.49) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL28427563 0.90 MEN1 (0.53) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL31723161 0.87 GABRP (0.56) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL31723173 0.87 MAPT (0.77) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL20918191 0.87 MAPT (0.77) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL31723150 0.87 MAPT (0.70) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL28427581 0.87 MAPT (0.70) ALDH1A1KDM4EMEN1MAPTHTT
SCHEMBL20919202 0.86 MAPT (0.52) ALDH1A1KDM4EMEN1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed